Abstract: p53, a tumor suppressor and a transcription factor, binds DNA in a sequence-specific manner. In more than half of human cancers, p53 has been found to be mutated with the loss of DNA-binding ability. In this review, we focus on the sensitive detection of interaction of tumor suppressor p53 with double-stranded DNA bearing the consensus sequence and proteins, such as monoclonal antibodies recognizing the p53 protein and metalloprotein. Relying on the specific binding of p53 to DNA and antibodies, quantitative determination of wild-type and mutant p53 proteins in normal and cancer cell lysates has been achieved.
INTRODUCTION
p53, a tumor suppressor and a transcription factor, has been purported to play an important role in cell cycle arrest or apoptosis upon activation by the stress signals to the normal mammalian cells [1] [2] [3] . The configuration of p53 was characterized by the three distinct functional domains, viz., the transactivation domain at the N-terminus, the specific DNA-binding core domain, and the tetramerization domain near the C-terminus ( Fig. 1 ) [4] [5] [6] [7] . More than half of human cancer cases have mutations in the p53 gene in which over one thousand mutations have been identified [4, [8] [9] [10] [11] [12] [13] . However, these mutations are mainly confined in the four conserved regions in the core domain of p53 ( Fig. 1) [4, [9] [10] [11] [12] [13] .
Via the oligomerization domain at the C-terminus, p53 usually adopts a tetramer structure [4, 7, 14] . The tetramer binds to the consensus double-stranded (ds-) DNA with sites comprising two or more copies of half-site. Each half-site contains 10 base pairs with a sequence of PuPuPuC(A/T)(T/A)GPyPyPy (where Pu and Py denote purines and pyrimidines, respectively [4, [15] [16] [17] [18] [19] [20] [21] ). Thus, one p53 monomer binds to half of the 10 base pair half-site (quartersite) (Fig. 2) .
INTERACTION OF p53 WITH DNA AND PROTEINS
Palecek and co-workers carried out a series of interesting work on the p53/DNA binding [22] [23] [24] [25] . Preferential binding of human or rat wild-type p53 to negatively supercoiled (sc) plasmid DNA has been reported based on electrophoretic retardation of scDNA on agarose gels and scanning force microscopy imaging [23] . The binding sites were found to be located in the core domain and the C-terminal domain of p53. Such an interaction has a biological implication with respect to the novel DNA binding activities of p53. Transmission electron microscopy has been utilized to characterize *Address correspondence to this author at the School of Chemistry and Chemical Engineering, Central South University, Changsha, Hunan, People's Republic of China 410083; E-mail: jxiuwang@mail.csu.edu.cn the salt-dependent bending of linear DNA duplexes induced by full-length wild-type p53 and p53 core domain/DNA interactions [25] . The resulting complex, with the core domain of p53 playing an important role, exhibits a broad bending angle distribution under low salt conditions. In another work by the same author, a quick and modified enzyme-linked immunosorbant assay (ELISA) has been developed for the analysis of p53/DNA interactions [22] . Streptavidin-coated microplates have been utilized to capture the p53/DNA complex in which the oligonucleotides containing p53 consensus sequences (p53CON) have been pre-tagged with biotin. The surface was then derivatized with peroxidase-conjugated antibodies recognizing p53. The specific binding of p53 to p53CON was evidenced by absorbance of the product formed during the catalytic reaction.
Due to the relatively low cellular p53 concentrations (from low picomolar to nanomolar levels), we have developed an amplified voltammetric method for detection of wild-type p53 from normal and cancer cell lysates using ferrocene-capped gold nanoparticle/streptavidin conjugates [26] . Consensus double-stranded oligonucleotides (dsODNs) were tethered onto the gold electrode for capture of wild-type p53 protein. Several surface binding configurations exist, among them, binding of p53 tetramers onto the full binding sites of individual ds-ODNs is the most stable form (Fig. 3A ) [26] [27] [28] . Upon derivatization of the free cysteine residues on the p53 molecules with N-biotinoyl-N'- [6-maleimidohexanoyl] hydrazide (biotin-Mi) [29] , biotin/streptavidin complexation renders the incorporation of the ferrocene-capped gold nanoparticle/streptavidin conjugates onto the electrode surface. Because each gold nanoparticle is decorated with more than 100 ferrocene (Fc) moieties [30, 31] , the voltammetric signals that report on the specific interaction of p53 with consensus ds-ODNs have been greatly enhanced (Fig. 3B) . However, in the cases of nonconsensus ds-ODNs and single-stranded (ss-) ODN, no discernable electrochemical signals were obtained. The present method has been utilized successfully for analysis of wildtype p53 in real samples. The concentration of the wild-type p53 in colorectal cancer cell lysates was found to be about 50 times lower than that from normal epithelial kidney cell lysates, indicating the feasibility of the method for indication of the mutation of p53 gene and quantification of the wildtype p53 in cancer cells. Our method is highly complementary to ELISA, as the precipitous decline of the wild-type p53 concentration in cancer cell lysates is accompanied by a significantly higher total p53 concentration (wild-type and mutant combined) determined by ELISA.
Surface plasmon resonance (SPR) is a sensitive optical technique capable of monitoring extremely small changes of thickness induced by biological reactions occurring at thin metal films [32] [33] [34] [35] . Campagnolo et al. have measured the interaction between p53 and serum p53 antibodies in cancer patient sera samples using SPR [36] . Polyhistidine tagged recombinant p53 proteins were tethered onto the SPR substrate via the well-known Ni-NTA (nickel-nitrilotriacetic acid) chemistry [37, 38] . The formation of the Ni-NTA functionalized surface involves the immobilization of 16-mercaptohexadecanoic acid, conversion of the terminal acid groups to the reactive anhydride, linker linkage, and then nickel chelation. Relying on the specific recognition between antigens and antibodies, qualitative analysis of serum antibodies in cancer patient sera has been demonstrated. Recently, we have reported the simultaneous and label-free determination of wild-type and mutant p53 proteins in normal and cancer cell lysates using a dual-channel SPR instrument [39] . One channel was modified with a consensus double-stranded DNA for capture of wild-type p53, while the other one was derivatized with a monoclonal antibody (PAb421) for recognition of total p53 (wild-type and mutant combined) (Fig. 4) . The difference between the SPR signals from the two channels via injection of the sample solution reveals the extent of p53 mutation. Higher levels of mutant p53 in cancer cell lines were observed, which was accompanied by a concomitant decease of the wild-type p53 concentration. Among the two normal cell lysates (liver cell L-02 and endothelial cell ECV-304) and two cancer cell lysates (liver cancer cell HepG-2 and colorectal cancer cell SW620) investigated, the mutation percentages in L-02 and ECV-304 deduced by taking the ratios of the concentrations of the mutant p53 over those of the total p53 are much smaller than those in HepG-2 and SW620. The trend that the p53 gene had been severely mutated in cancer cell lines monitored by SPR is in line with the ELISA. The dual-channel SPR has been shown to be a convenient alternative to conventional and laborious immunoassays in that it does not involve the use of a second antibody labeled with an enzyme and can real-time monitor the binding reactions. The present method can determine low picomolar levels of wild-type and total p53 proteins on a single SPR chip though no amplification scheme was involved.
Metallothionein (MT), a low-molecular-weight and cysteine-rich protein, was discovered in 1957 by Margoshes and Vallee [40] . The strong binding of cysteine residues to the transition-metal ions in MTs enables the formation of the dumbbell-like structure, which has an interesting implication with respect to the regulation of essential metals, detoxification of nonessential metals, and scavenging of free radicals [40] [41] [42] . It has been reported that in certain tumor cells, high expression of MTs is concerned with the existence of mutant p53 [43, 44] . Based on SPR, we have examined the specific interaction of p53 with apo-metallothionein (apo-MT, the metal-free form of MT [45] [46] [47] ) (Fig. 5) , providing a simple, sensitive, and label-free strategy for monitoring p53 conformational change and transcriptional activity regulated by the MT/apo-MT couple [48] . Being different from the conventional methods, such as immunoprecipitation [45, 49] , the use of an SPR chip provides higher fidelity and simplicity to assessment of the interaction of p53 with apo-MT. Such an interaction was originated from the high binding affinity of free sulfhydryl groups of apo-MT with Zn 2+ of p53, causing p53 to adopt a "mutant like" form with loss of sequencespecific DNA-binding activity [45, 49] . Further results also indicate that interaction of p53 with apo-MT has been impeded by the steric hindrance imposed by the preformed p53/ds-DNA complex, as evidenced by the essentially unchanged SPR angle at the chip covered with apo-MT upon injection of the mixture of p53 and consensus ds-DNA. The SPR results were consistent with the fluorescence measurements in which significant change in the fluorescence signal of the tryptophan residues of wild-type p53 [50] [51] [52] was obtained upon addition of apo-MT.
CONCLUSIONS AND OUTLOOK
Due to the important roles of p53 in maintenance of genome integrity, p53 has been examined extensively in cancer research over the past years. In this review, examples concerning the interaction of tumor suppressor p53 with consensus double-stranded DNA and proteins have been highlighted. From the examples described above, it is evident that the integration of nanomaterials with electrochemistry or the successful utilization of SPR has opened up new opportunities for sensitive and selective determination of wild-type and mutant p53 concentrations in normal and cancer cell lysates. With the full exploration of the function of p53 as the tumor suppressor along with the progress in existing detection methods, a multitude of techniques for rapid, sensitive, reliable, and label-free caner diagnoses will be developed in the near future. 
